Market Intelligence chevron_right Medical Care chevron_right Retinal Disorder Treatment
Global Report 2022

Global Retinal Disorder Treatment Market Research Report 2023

calendar_todayPublished: Jun 2022 descriptionPages: 89 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinal Disorder Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Gels
        1.2.3 Capsules & Tablets
        1.2.4 Eye Drops
        1.2.5 Ointments
    1.3 Market by Application
        1.3.1 Global Retinal Disorder Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Online Pharmacy
        1.3.4 Retail Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Retinal Disorder Treatment Market Perspective (2017-2028)
    2.2 Retinal Disorder Treatment Growth Trends by Region
        2.2.1 Retinal Disorder Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Retinal Disorder Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Retinal Disorder Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Retinal Disorder Treatment Market Dynamics
        2.3.1 Retinal Disorder Treatment Industry Trends
        2.3.2 Retinal Disorder Treatment Market Drivers
        2.3.3 Retinal Disorder Treatment Market Challenges
        2.3.4 Retinal Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinal Disorder Treatment Players by Revenue
        3.1.1 Global Top Retinal Disorder Treatment Players by Revenue (2017-2022)
        3.1.2 Global Retinal Disorder Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Retinal Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinal Disorder Treatment Revenue
    3.4 Global Retinal Disorder Treatment Market Concentration Ratio
        3.4.1 Global Retinal Disorder Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorder Treatment Revenue in 2021
    3.5 Retinal Disorder Treatment Key Players Head office and Area Served
    3.6 Key Players Retinal Disorder Treatment Product Solution and Service
    3.7 Date of Enter into Retinal Disorder Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorder Treatment Breakdown Data by Type
    4.1 Global Retinal Disorder Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Retinal Disorder Treatment Forecasted Market Size by Type (2023-2028)
5 Retinal Disorder Treatment Breakdown Data by Application
    5.1 Global Retinal Disorder Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Retinal Disorder Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Retinal Disorder Treatment Market Size (2017-2028)
    6.2 North America Retinal Disorder Treatment Market Size by Country (2017-2022)
    6.3 North America Retinal Disorder Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Retinal Disorder Treatment Market Size (2017-2028)
    7.2 Europe Retinal Disorder Treatment Market Size by Country (2017-2022)
    7.3 Europe Retinal Disorder Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinal Disorder Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Retinal Disorder Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Retinal Disorder Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Retinal Disorder Treatment Market Size (2017-2028)
    9.2 Latin America Retinal Disorder Treatment Market Size by Country (2017-2022)
    9.3 Latin America Retinal Disorder Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinal Disorder Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Santen Pharmaceutical
        11.1.1 Santen Pharmaceutical Company Detail
        11.1.2 Santen Pharmaceutical Business Overview
        11.1.3 Santen Pharmaceutical Retinal Disorder Treatment Introduction
        11.1.4 Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.1.5 Santen Pharmaceutical Recent Development
    11.2 REGENERON
        11.2.1 REGENERON Company Detail
        11.2.2 REGENERON Business Overview
        11.2.3 REGENERON Retinal Disorder Treatment Introduction
        11.2.4 REGENERON Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.2.5 REGENERON Recent Development
    11.3 Graybug Vision
        11.3.1 Graybug Vision Company Detail
        11.3.2 Graybug Vision Business Overview
        11.3.3 Graybug Vision Retinal Disorder Treatment Introduction
        11.3.4 Graybug Vision Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.3.5 Graybug Vision Recent Development
    11.4 Takeda Pharmaceuticals
        11.4.1 Takeda Pharmaceuticals Company Detail
        11.4.2 Takeda Pharmaceuticals Business Overview
        11.4.3 Takeda Pharmaceuticals Retinal Disorder Treatment Introduction
        11.4.4 Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.4.5 Takeda Pharmaceuticals Recent Development
    11.5 Bayer
        11.5.1 Bayer Company Detail
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Retinal Disorder Treatment Introduction
        11.5.4 Bayer Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.5.5 Bayer Recent Development
    11.6 Roche-Genentech
        11.6.1 Roche-Genentech Company Detail
        11.6.2 Roche-Genentech Business Overview
        11.6.3 Roche-Genentech Retinal Disorder Treatment Introduction
        11.6.4 Roche-Genentech Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.6.5 Roche-Genentech Recent Development
    11.7 Acucela
        11.7.1 Acucela Company Detail
        11.7.2 Acucela Business Overview
        11.7.3 Acucela Retinal Disorder Treatment Introduction
        11.7.4 Acucela Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.7.5 Acucela Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Retinal Disorder Treatment Introduction
        11.8.4 Pfizer Revenue in Retinal Disorder Treatment Business (2017-2022)
        11.8.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinal Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Gels
    Table 3. Key Players of Capsules & Tablets
    Table 4. Key Players of Eye Drops
    Table 5. Key Players of Ointments
    Table 6. Global Retinal Disorder Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Retinal Disorder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Retinal Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Retinal Disorder Treatment Market Share by Region (2017-2022)
    Table 10. Global Retinal Disorder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Retinal Disorder Treatment Market Share by Region (2023-2028)
    Table 12. Retinal Disorder Treatment Market Trends
    Table 13. Retinal Disorder Treatment Market Drivers
    Table 14. Retinal Disorder Treatment Market Challenges
    Table 15. Retinal Disorder Treatment Market Restraints
    Table 16. Global Retinal Disorder Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Retinal Disorder Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorder Treatment as of 2021)
    Table 19. Ranking of Global Top Retinal Disorder Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Retinal Disorder Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Retinal Disorder Treatment Product Solution and Service
    Table 23. Date of Enter into Retinal Disorder Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Retinal Disorder Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Retinal Disorder Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Retinal Disorder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Retinal Disorder Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Retinal Disorder Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Retinal Disorder Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Retinal Disorder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Retinal Disorder Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Retinal Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Retinal Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Retinal Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Retinal Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Retinal Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Retinal Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Santen Pharmaceutical Company Detail
    Table 44. Santen Pharmaceutical Business Overview
    Table 45. Santen Pharmaceutical Retinal Disorder Treatment Product
    Table 46. Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 47. Santen Pharmaceutical Recent Development
    Table 48. REGENERON Company Detail
    Table 49. REGENERON Business Overview
    Table 50. REGENERON Retinal Disorder Treatment Product
    Table 51. REGENERON Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 52. REGENERON Recent Development
    Table 53. Graybug Vision Company Detail
    Table 54. Graybug Vision Business Overview
    Table 55. Graybug Vision Retinal Disorder Treatment Product
    Table 56. Graybug Vision Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 57. Graybug Vision Recent Development
    Table 58. Takeda Pharmaceuticals Company Detail
    Table 59. Takeda Pharmaceuticals Business Overview
    Table 60. Takeda Pharmaceuticals Retinal Disorder Treatment Product
    Table 61. Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 62. Takeda Pharmaceuticals Recent Development
    Table 63. Bayer Company Detail
    Table 64. Bayer Business Overview
    Table 65. Bayer Retinal Disorder Treatment Product
    Table 66. Bayer Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 67. Bayer Recent Development
    Table 68. Roche-Genentech Company Detail
    Table 69. Roche-Genentech Business Overview
    Table 70. Roche-Genentech Retinal Disorder Treatment Product
    Table 71. Roche-Genentech Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 72. Roche-Genentech Recent Development
    Table 73. Acucela Company Detail
    Table 74. Acucela Business Overview
    Table 75. Acucela Retinal Disorder Treatment Product
    Table 76. Acucela Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 77. Acucela Recent Development
    Table 78. Pfizer Company Detail
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Retinal Disorder Treatment Product
    Table 81. Pfizer Revenue in Retinal Disorder Treatment Business (2017-2022) & (US$ Million)
    Table 82. Pfizer Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinal Disorder Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Gels Features
    Figure 3. Capsules & Tablets Features
    Figure 4. Eye Drops Features
    Figure 5. Ointments Features
    Figure 6. Global Retinal Disorder Treatment Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Online Pharmacy Case Studies
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. Retinal Disorder Treatment Report Years Considered
    Figure 11. Global Retinal Disorder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Retinal Disorder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Retinal Disorder Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Retinal Disorder Treatment Market Share by Players in 2021
    Figure 15. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorder Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Retinal Disorder Treatment Revenue in 2021
    Figure 17. North America Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Retinal Disorder Treatment Market Share by Country (2017-2028)
    Figure 19. United States Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Retinal Disorder Treatment Market Share by Country (2017-2028)
    Figure 23. Germany Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Retinal Disorder Treatment Market Share by Region (2017-2028)
    Figure 31. China Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Retinal Disorder Treatment Market Share by Country (2017-2028)
    Figure 39. Mexico Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Retinal Disorder Treatment Market Share by Country (2017-2028)
    Figure 43. Turkey Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Retinal Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Santen Pharmaceutical Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 46. REGENERON Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 47. Graybug Vision Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 48. Takeda Pharmaceuticals Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 49. Bayer Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 50. Roche-Genentech Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 51. Acucela Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Retinal Disorder Treatment Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Santen Pharmaceutical
REGENERON
Graybug Vision
Takeda Pharmaceuticals
Bayer
Roche-Genentech
Acucela
Pfizer

Frequently Asked Questions

What is the USP of the report? expand_more
Retinal Disorder Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Retinal Disorder Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Retinal Disorder Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.